Skip to content
Tenfell
Awarded contract
Published 22 Jan 2021

SARS-CoV-2 (2019-nCoV) Spike RBD(N501Y)-His Recombinant Protein for Covid 19 activity (new variant strain of Covid).

Public Health England · United Kingdom

Key facts

Contract value
£11,150
Awarded
30 Dec 2020
Contract starts
30 Dec 2020
Contract ends
31 Mar 2021
Procedure
Single tender action (below threshold)
Buyer type
Central government

Awarded to

SupplierValue
Sino Biological£11,150

Description

The Government must protect the health and well-being of UK citizens. The COVID-19 outbreak is a Public Health Emergency of International Concern (PHEIC) as declared by the World Health Organisation on 30 Jan 2020. The WHO Director General characterised COVID-19 as a pandemic on 11 March 2020.

Public Health England (PHE) discharges its duties as a Category 1 Responder to emergencies on behalf of the Secretary of State for Health within the scope of the Civil Contingencies Act 2004 (CCA 2004).

This requirement is in response to the recent COVID -19 outbreak. PHE has awarded a contract to Sino Biological for the purchase of SARS-CoV-2 (2019-nCoV) Spike RBD(N501Y)-His Recombinant Protein for Covid 19 activity (new variant strain of Covid) due to extreme urgency under current public procurement regulations using regulation 32(2)(c).

Categories (CPV)

Similar open tenders

About Public Health England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.